C677T and A1298C methylenetetrahydropholate reductase (MTHFR) polymorphisms as factors involved in ischemic stroke

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 4, 2011, Pages 1203-1207

  Arsene, D ^a   Gǎinǎ, Gisela ^a   Bǎlescu, Carmen ^b   Ardeleanu, Carmen ^a  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

A1298C; CC677T; Gene polymorphisms; Ischemic stroke; Methylenetetrahydropholate reductase; Pathogenesis

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AGED; ARTICLE; BRAIN ISCHEMIA; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; STAINING; STROKE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STAINING AND LABELING; STROKE;

EID: 84855467089     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association, Circulation, 2010, 121(7):948-954.
2. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ, Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association, Stroke, 2001, 32(1):280-299.
3. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS, Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults, Blood, 2003, 101(7):2483-2488.
4. Gellekink H, den Heijer M, Heil SG, Blom HJ, Genetic determinants of plasma total homocysteine, Semin Vasc Med, 2005, 5(2):98-109.
5. Wald DS, Law M, Morris JK, Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis, BMJ, 2002, 325(7374):1202.
6. Homocysteine Studies Collaboration, Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis, JAMA, 2002, 288(16):2015-2022.
7. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat Genet, 1995, 10(1):111-113.
8. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD, Homocysteine and stroke: evidence on a causal link from Mendelian randomisation, Lancet, 2005, 365(9455):224-232.
9. Al-Allawi NA, Avo AS, Jubrael JM, Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke, Neurol India, 2009, 57(5):631-635.
10. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr, 5,10- Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects, Am J Med Genet, 1996, 63(4):610-614.
11. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK, Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis, Fertil Steril, 2000, 74(6):1196-1199.
12. Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D, Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions, Thromb Res, 2003, 111(1-2):39-44.
13. Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C, Trabetti E, Faccini G, Tinazzi E, Pignatti PF, Corrocher R, The interaction between MTHFR 677 C-->T genotype and folate status is a determinant of coronary atherosclerosis risk, J Nutr, 2003, 133(5):1281-1285.
14. Heijmans BT, Boer JM, Suchiman HE, Cornelisse CJ, Westendorp RG, Kromhout D, Feskens EJ, Slagboom PE, A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer, Cancer Res, 2003, 63(6):1249-1253.
15. Kim NK, Choi YK, Kang MS, Choi DH, Cha SH, An MO, Lee S, Jeung M, Ko JJ, Oh D, Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion, Thromb Res, 2006, 117(6):653-658.
16. Ko KH, Kim NK, Yim DJ, Hong SP, Park PW, Rim KS, Kim S, Hwang SG, Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population, Anticancer Res, 2006, 26(6B):4229-4233.
17. Sun JZ, Xu Y, Lu H, Zhu Y, Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes, Neurol India, 2009, 57(5):589-593.
18. Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, Breteler MM, Bautista LE, Sharma P, Whittaker JC, Smeeth L, Fowkes FG, Algra A, Shmeleva V, Szolnoki Z, Roest M, Linnebank M, Zacho J, Nalls MA, Singleton AB, Ferrucci L, Hardy J, Worrall BB, Rich SS, Matarin M, Norman PE, Flicker L, Almeida OP, van Bockxmeer FM, Shimokata H, Khaw KT, Wareham NJ, Bobak M, Sterne JA, Smith GD, Talmud PJ, van Duijn C, Humphries SE, Price JF, Ebrahim S, Lawlor DA, Hankey GJ, Meschia JF, Sandhu MS, Hingorani AD, Casas JP, Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials, Lancet, 2011, 378(9791):584-594.
19. Low HQ, Chen CP, Kasiman K, Thalamuthu A, Ng SS, Foo JN, Chang HM, Wong MC, Tai ES, Liu J, A comprehensive association analysis of homocysteine metabolic pathway genes in Singaporean Chinese with ischemic stroke, PLoS One, 2011, 6(9):e24757.
20. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R, A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity, Mol Genet Metab, 1998, 64(3):169-172.
21. van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ, A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet, 1998, 62(5):1044-1051.
22. Stegmann K, Ziegler A, Ngo ET, Kohlschmidt N, Schröter B, Ermert A, Koch MC, Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD), Am J Med Genet, 1999, 87(1):23-29.
23. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q, Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study, Int J Cancer, 2001, 95(5):332-336.
24. Song C, Xing D, Tan W, Wei Q, Lin D, Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population, Cancer Res, 2001, 61(8):3272-3275.
25. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura S, Seto M, Morishima Y, Tajima K, Association between polymorphisms of folate- and methioninemetabolizing enzymes and susceptibility to malignant lymphoma, Blood, 2001, 97():3205-3209.
26. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I, Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C, Brain Res Bull, 2006, 71():45-50.
27. Han IB, Kim OJ, Ahn JY, Oh D, Hong SP, Huh R, Chung SS, Kim NK, Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population, Yonsei Med J, 2010, 51(2):253-260.
28. Goracy I, Cyrylowski L, Kaczmarczyk M, Fabian A, Koziarska D, Goracy J, Ciechanowicz A, C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects, J Appl Genet, 2009, 50(1):63-67.
29. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y, Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease, Circulation, 1997, 95(8):2032-2036.
30. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R; Multicenter Case-Control Study in China, Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China, Stroke, 2003, 34(9):2085-2090.
31. Alluri RV, Mohan V, Komandur S, Chawda K, Chaudhuri JR, Hasan Q, MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study, Eur J Neurol, 2005, 12(1):40-44.
32. Mejia Mohamed EH, Tan KS, Ali JM, Mohamed Z, TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients, Ann Acad Med Singapore, 2011, 40(4):186-186.
33. Soriente L, Coppola A, Madonna P, Cerbone AM, Di Minno G, Orefice G, D'Angelo A, Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke, Stroke, 1998, 29(4):869-871.
34. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J, A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease, Stroke, 1997, 28(9):1739-1743.
35. Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, Eggertsen G, Kostulas V, Hillert J, A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis, Eur J Clin Invest, 1998, 28(4):285-289.
36. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Dahlén G, Olsson T, Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke, Stroke, 1999, 30(5):974-980.
37. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI, Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke, Stroke, 2000, 31(5):1069-1075.
38. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A, Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke, Stroke, 2002, 33(3):664-669.
39. Isordia-Salas I, Barinagarrementería-Aldatz F, Leaños- Miranda A, Borrayo-Sánchez G, Vela-Ojeda J, García- Chávez J, Ibarra-González I, Majluf-Cruz A, The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population, Cerebrovasc Dis, 2010, 29(5):454-459.
40. Kalita J, Srivastava R, Bansal V, Agarwal S, Misra UK, Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients, Neurol India, 2006, 54(3):260-263.